Cigna Group
NYSE:CI Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 72 Fair Values set on narratives written by author
WA
Consensus Narrative from 24 Analysts
Expansion Of EnCircleRx And AI Diagnostics Will Improve Personalized Healthcare
Key Takeaways Anticipated biosimilar ramp-up and Evernorth client growth expected to boost revenue and margins, supporting overall financial performance. Divestiture funds for share repurchases likely to enhance earnings through EPS accretion, aiding earnings growth.
View narrativeUS$389.54
FV
23.0% undervalued intrinsic discount6.38%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
14users have followed this narrative
24 days ago author updated this narrative